[go: up one dir, main page]

ES483247A1 - Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos - Google Patents

Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos

Info

Publication number
ES483247A1
ES483247A1 ES483247A ES483247A ES483247A1 ES 483247 A1 ES483247 A1 ES 483247A1 ES 483247 A ES483247 A ES 483247A ES 483247 A ES483247 A ES 483247A ES 483247 A1 ES483247 A1 ES 483247A1
Authority
ES
Spain
Prior art keywords
substituted
diazacycloalkenes
thio
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483247A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES483247A1 publication Critical patent/ES483247A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Luminescent Compositions (AREA)

Abstract

Procedimiento para la obtención de nuevos diazacicloalquenos tiosustituidos, en particular de compuestos de fórmula **(Fórmula)** en la que R1 y R2 independientemente entre sí, significan grupos arilo o grupos heteroarilos en caso dado sustituidos, R3 significa hidrógeno o alquilo inferior y R4 significa un resto de hidrocarburo alifático en caso dado sustituido, y sus sales.
ES483247A 1978-08-10 1979-08-08 Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos Expired ES483247A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH852678 1978-08-10

Publications (1)

Publication Number Publication Date
ES483247A1 true ES483247A1 (es) 1980-04-16

Family

ID=4341567

Family Applications (1)

Application Number Title Priority Date Filing Date
ES483247A Expired ES483247A1 (es) 1978-08-10 1979-08-08 Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos

Country Status (15)

Country Link
US (1) US4308277A (es)
EP (1) EP0008073A1 (es)
JP (1) JPS5547660A (es)
AU (1) AU4973979A (es)
CA (1) CA1130288A (es)
DD (1) DD145269A5 (es)
DK (1) DK333279A (es)
ES (1) ES483247A1 (es)
FI (1) FI792449A7 (es)
GR (1) GR72493B (es)
IL (1) IL58007A0 (es)
NO (1) NO792597L (es)
PL (2) PL217683A1 (es)
PT (1) PT70046A (es)
ZA (1) ZA794156B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0004648B1 (de) * 1978-04-11 1982-08-25 Ciba-Geigy Ag Neue Mercaptoimidazolderivate, Verfahren zu deren Herstellung, Mercaptoimidazolderivate zur Behandlung entzündlicher Erkrankungen und diese enthaltende pharmazeutische Präparate
DE3337180A1 (de) * 1983-10-13 1985-04-25 Hoechst Ag, 6230 Frankfurt Neue 5-substituierte -(delta)2-imidazolinyl-thioether und verfahren zu iherer herstellung
DE3337181A1 (de) * 1983-10-13 1985-04-25 Hoechst Ag, 6230 Frankfurt Neue 4-substituierte-(delta) 2-imidazolinyl-thioether und verfahren zu ihrer herstellung
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
GB0324498D0 (en) * 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981739A (en) * 1958-01-27 1961-04-25 Diamond Alkali Co Certain alpha-haloaldehyde addition products of ethylenethioureas and process
SE428686B (sv) * 1975-08-11 1983-07-18 Du Pont Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
US4190666A (en) * 1975-08-11 1980-02-26 E. I. Du Pont De Nemours And Company Anti-inflammatory 4,5-diarly-2-(substituted-thio)imidazoles and their corresponding sulfoxides and sulfones
ZA78768B (en) * 1977-02-09 1979-01-31 Du Pont Anti-inflammatory imidazoles and their corresponding sulfoxides and sulfones
US4182769A (en) * 1977-02-09 1980-01-08 E. I. Du Pont De Nemours And Company Anti-inflammatory 1-substituted-4,5-diaryl-2-(substituted-thio) imidazoles and their corresponding sulfoxides and sulfones

Also Published As

Publication number Publication date
PT70046A (en) 1979-09-01
PL224554A1 (es) 1982-02-01
DK333279A (da) 1980-02-11
GR72493B (es) 1983-11-15
DD145269A5 (de) 1980-12-03
NO792597L (no) 1980-02-12
FI792449A7 (fi) 1981-01-01
JPS5547660A (en) 1980-04-04
IL58007A0 (en) 1979-12-30
CA1130288A (en) 1982-08-24
US4308277A (en) 1981-12-29
AU4973979A (en) 1980-02-14
PL217683A1 (es) 1980-11-03
ZA794156B (en) 1980-08-27
EP0008073A1 (de) 1980-02-20

Similar Documents

Publication Publication Date Title
DE3069633D1 (en) Propenylamines, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
IL68075A0 (en) Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them
DE3173080D1 (en) Pyrimidine-2-sulphides and their s-oxides for use in medicine, pharmaceutical compositions containing them, processes for their preparation and such compounds when novel per se
FR2307528B1 (es)
ATE13765T1 (de) 2-(1,4-benzodioxan-2-ylalkyl)-imidazole, deren herstellung und sie enthaltende pharmazeutische mittel.
ES483247A1 (es) Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos
ZA84668B (en) Novel derivatives of n-iminopyridinium betaines,their preparation and their application as medicaments
ES476645A1 (es) Procedimiento para la obtencion de derivados aminados de pi-razol (1,5-a)s troazina.
ES8301239A1 (es) Procedimiento para la preparacion de nitratos de alquilami- nodesoxi-1.4,3.6-dianhidro-hexito sustituidos con bases pu- rinicas
ES476354A1 (es) Procedimientos para la obtencion de nuevos derivados de ari-laminoimidazolina.
DE3272892D1 (en) Substituted pyrimid-2-ones, the salts thereof, processes for their preparation and pharmaceutical compositions containing them
ES488388A1 (es) Procedimiento de preparacion de derivados hidroxilados del tiazol
FR2494274B2 (es)
ATE1550T1 (de) Clavulansaeurederivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES8305367A1 (es) "procedimiento para la preparacion de nuevas penicilinas".
ES450211A1 (es) Procedimiento para la obtencion de nuevos derivados de la 1-hidroxi-benzo-2,3,1-diazaborina.
ES8107202A1 (es) Procedimiento para preparar nuevos derivados de oxadiazolin-1,3,4-ona-5.